| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005709292 |
| P356 | DOI | 10.1186/1742-2094-11-92 |
| P8608 | Fatcat ID | release_u75wl6forrgfvjs5rsycon5x6q |
| P932 | PMC publication ID | 4046049 |
| P698 | PubMed publication ID | 24884664 |
| P5875 | ResearchGate publication ID | 262810169 |
| P50 | author | Jenny Wilkerson | Q61449715 |
| P2093 | author name string | Audra A Kerwin | |
| Erin D Milligan | |||
| James A Wallace | |||
| Brandi N Bowman | |||
| Ellen C Dengler | |||
| Daniel R Moezzi | |||
| Eugene Limanovich | |||
| Lauren A Alberti | |||
| P2860 | cites work | The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population Survey | Q21710682 |
| Interleukin-10 and the interleukin-10 receptor | Q24290912 | ||
| Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain | Q24634125 | ||
| Pathological and protective roles of glia in chronic pain | Q24646738 | ||
| Chemokines and the pathophysiology of neuropathic pain | Q24683873 | ||
| Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10 | Q24796221 | ||
| Interleukin-10 enhances the CD14-dependent phagocytosis of bacteria and apoptotic cells by human monocytes. | Q52923359 | ||
| Multiple effects of a short-term dexamethasone treatment in human skeletal muscle and adipose tissue | Q56601695 | ||
| Expression of CCR2 in Both Resident and Bone Marrow-Derived Microglia Plays a Critical Role in Neuropathic Pain | Q56886107 | ||
| Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury | Q56886108 | ||
| "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig | Q56901846 | ||
| Mannose receptor mediated antigen uptake and presentation in human dendritic cells | Q57275947 | ||
| Mirror-image pain is mediated by nerve growth factor produced from tumor necrosis factor alpha-activated satellite glia after peripheral nerve injury | Q60697722 | ||
| Inhibition of adjuvant arthritis in the rat by phosphosugars and the α‐glucosidase inhibitor castanospermine | Q67472784 | ||
| Production of interleukin-10 by mouse glial cells in culture | Q72384505 | ||
| Tyrosine hydroxylase-containing neurons in the spinal cord of the chicken. I. Development and analysis of catecholamine synthesis capabilities | Q73024129 | ||
| Regional and temporal expression patterns of interleukin-10, interleukin-10 receptor and adhesion molecules in the rat spinal cord during chronic relapsing EAE | Q73087385 | ||
| Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases | Q74463517 | ||
| Effects of hexose sugars: glucose, fructose, galactose and mannose on wound healing in the rat | Q74596025 | ||
| Identification and functional characterization of the mannose receptor in astrocytes | Q77794223 | ||
| Focal peripheral nerve injury induces leukocyte trafficking into the central nervous system: potential relationship to neuropathic pain | Q78524711 | ||
| Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses | Q79652930 | ||
| Comparison of five different rat models of peripheral nerve injury | Q81277148 | ||
| CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells | Q81391451 | ||
| Spinal interleukin-10 therapy to treat peripheral neuropathic pain | Q26861391 | ||
| Alternative activation of macrophages | Q27860939 | ||
| Neuropsin promotes oligodendrocyte death, demyelination and axonal degeneration after spinal cord injury | Q27863364 | ||
| The mannose receptor family | Q28201143 | ||
| Mannose receptor-mediated regulation of serum glycoprotein homeostasis | Q28205913 | ||
| The mannose receptor is a pattern recognition receptor involved in host defense | Q28266161 | ||
| Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis | Q28291353 | ||
| Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain | Q28583865 | ||
| Alternative activation of macrophages: an immunologic functional perspective | Q29614353 | ||
| Quantitative assessment of tactile allodynia in the rat paw | Q29617366 | ||
| Structural basis of integrin regulation and signaling | Q29617618 | ||
| Microglia: a sensor for pathological events in the CNS | Q29620556 | ||
| Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. | Q30326539 | ||
| Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. | Q31917601 | ||
| Glycine inhibitory dysfunction turns touch into pain through PKCgamma interneurons | Q33305201 | ||
| PEGylation of interleukin-10 for the mitigation of enhanced pain states | Q33505369 | ||
| Does the right side know what the left is doing? | Q33591945 | ||
| T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. | Q33619939 | ||
| Pathological pain and the neuroimmune interface | Q33925677 | ||
| Mannose receptor and scavenger receptor: two macrophage pattern recognition receptors with diverse functions in tissue homeostasis and host defense. | Q33970069 | ||
| The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques | Q34124090 | ||
| CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain | Q34235603 | ||
| Alternatively activated antigen-presenting cells: molecular repertoire, immune regulation, and healing. | Q34390977 | ||
| CpG motifs in bacterial DNA and their immune effects | Q34542287 | ||
| A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. | Q34554719 | ||
| Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil | Q34589502 | ||
| Prevalence of chronic pain with neuropathic characteristics in the general population. | Q34691911 | ||
| The prevalence and phenotype of activated microglia/macrophages within the spinal cord of the hyperostotic mouse (twy/twy) changes in response to chronic progressive spinal cord compression: implications for human cervical compressive myelopathy | Q34745966 | ||
| Dexamethasone-associated cross-linked actin network formation in human trabecular meshwork cells involves β3 integrin signaling | Q35027468 | ||
| How corticosteroids control inflammation: Quintiles Prize Lecture 2005 | Q35545886 | ||
| Mannose receptor | Q35654725 | ||
| Mannosylated biodegradable polyethyleneimine for targeted DNA delivery to dendritic cells. | Q36061998 | ||
| Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation | Q36231523 | ||
| Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy | Q36316635 | ||
| Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery | Q36409586 | ||
| Stability of neuropathic pain symptoms in partial sciatic nerve ligation in rats is affected by suture material | Q45165124 | ||
| Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury. | Q45933860 | ||
| Interleukin-10 and interleukin-10 receptor-I are upregulated in glial cells after an excitotoxic injury to the postnatal rat brain | Q46087826 | ||
| Bone marrow-derived cells in the central nervous system of a mouse model of amyotrophic lateral sclerosis are associated with blood vessels and express CX(3)CR1. | Q46109367 | ||
| Mannose prevents lipopolysaccharide-induced acute lung injury in rats | Q46680019 | ||
| Macrophages and dendritic cells in the rat meninges and choroid plexus: three-dimensional localisation by environmental scanning electron microscopy and confocal microscopy | Q47686882 | ||
| Immune cell involvement in dorsal root ganglia and spinal cord after chronic constriction or transection of the rat sciatic nerve. | Q48328700 | ||
| Peripheral nerve injury alters blood-spinal cord barrier functional and molecular integrity through a selective inflammatory pathway. | Q50436500 | ||
| Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery. | Q50523941 | ||
| Mannose inhibits the human neutrophil oxidative burst. | Q50897973 | ||
| Leptomeningeal cells activate microglia and astrocytes to induce IL-10 production by releasing pro-inflammatory cytokines during systemic inflammation. | Q51372902 | ||
| Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. | Q52041455 | ||
| Fitting the psychometric function. | Q52222385 | ||
| Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration | Q36642679 | ||
| Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status | Q36722852 | ||
| Cellular components of the immune barrier in the spinal meninges and dorsal root ganglia of the normal rat: immunohistochemical (MHC class II) and electron-microscopic observations | Q36768471 | ||
| Gene therapy applications for the treatment of neuropathic pain | Q36817045 | ||
| Immunogenicity of intrathecal plasmid gene delivery: cytokine release and effects on transgene expression | Q36831409 | ||
| Activation of P2X7 receptors in glial satellite cells reduces pain through downregulation of P2X3 receptors in nociceptive neurons | Q36954974 | ||
| The neuropathic pain triad: neurons, immune cells and glia | Q36983677 | ||
| Drug insight: selective agonists and antagonists of the glucocorticoid receptor | Q37062932 | ||
| Dexamethasone augments CXCR4-mediated signaling in resting human T cells via the activation of the Src kinase Lck | Q37066236 | ||
| A human trial of HSV-mediated gene transfer for the treatment of chronic pain | Q37195741 | ||
| Contribution of the activation of satellite glia in sensory ganglia to pathological pain | Q37376702 | ||
| Glia and pain: is chronic pain a gliopathy? | Q37381399 | ||
| Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain. | Q37388717 | ||
| Neuropathic pain: a maladaptive response of the nervous system to damage | Q37401775 | ||
| Long-term control of neuropathic pain in a non-viral gene therapy paradigm | Q37406988 | ||
| Cell motility is decreased in macrophages activated by cancer cell-conditioned medium | Q37429790 | ||
| Role of glia in orofacial pain | Q37867904 | ||
| Gene-based approaches in pain research and exploration of new therapeutic targets and strategies | Q38090293 | ||
| Neuropathic pain in the general population: a systematic review of epidemiological studies. | Q38167585 | ||
| Macrophage mannose receptor-specific gene delivery vehicle for macrophage engineering. | Q38309646 | ||
| Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia | Q39248070 | ||
| Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells | Q39271771 | ||
| Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats | Q39342133 | ||
| Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. | Q39972447 | ||
| Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery | Q39980708 | ||
| IL-4 regulation of p38 MAPK signalling is dependent on cell type. | Q40713494 | ||
| The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages | Q40816643 | ||
| Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels | Q41785702 | ||
| Role of the mannose receptor in phagocytosis of Enterococcus faecalis strain EC-12 by antigen-presenting cells. | Q41866558 | ||
| Transforming growth factor-beta1 impairs neuropathic pain through pleiotropic effects | Q41892208 | ||
| Non-viral gene delivery via membrane-penetrating, mannose-targeting supramolecular self-assembled nanocomplexes | Q41899969 | ||
| Activation of spinal microglia in a murine model of peripheral inflammation-induced, long-lasting contralateral allodynia. | Q42093594 | ||
| Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain | Q42095035 | ||
| Identification of novel markers of alternative activation and potential endogenous PPARγ ligand production mechanisms in human IL-4 stimulated differentiating macrophages | Q42512296 | ||
| Involvement of mannose receptor in the preventive effects of mannose in lipopolysaccharide-induced acute lung injury. | Q42966883 | ||
| Contralateral neuropathic pain and neuropathology in dorsal root ganglion and spinal cord following hemilateral nerve injury in rats | Q43497769 | ||
| Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. | Q43578202 | ||
| Regional and cellular expression of the mannose receptor in the post-natal developing mouse brain | Q43587252 | ||
| Gene transfer to dorsal root ganglia by intrathecal injection: effects on regeneration of peripheral nerves | Q44485844 | ||
| Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program | Q44625255 | ||
| Spinal gap junctions: potential involvement in pain facilitation | Q44718766 | ||
| The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse | Q44802693 | ||
| P921 | main subject | chronic pain | Q1088113 |
| neuropathic pain | Q2798704 | ||
| chronic neuropathic pain | Q58490835 | ||
| P304 | page(s) | 92 | |
| P577 | publication date | 2014-05-21 | |
| P1433 | published in | Journal of Neuroinflammation | Q15716679 |
| P1476 | title | Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain | |
| P478 | volume | 11 |
| Q39248404 | Chronic Sciatic Neuropathy in Rat Reduces Voluntary Wheel-Running Activity With Concurrent Chronic Mechanical Allodynia |
| Q92539077 | Cytokines in Pain: Harnessing Endogenous Anti-Inflammatory Signaling for Improved Pain Management |
| Q50426470 | Divergent roles of immune cells and their mediators in pain. |
| Q45874115 | Effects of spinal non-viral interleukin-10 gene therapy formulated with d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein analysis in pain relevant tissues. |
| Q48510107 | Gene transfer of a naked plasmid (pUDK-HGF) encoding human hepatocyte growth factor attenuates skin/muscle incision and retraction-induced chronic post-surgical pain in rats. |
| Q38893386 | Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse. |
| Q91688888 | IL-10 Gene-Modified Human Amniotic Mesenchymal Stem Cells Augment Regenerative Wound Healing by Multiple Synergistic Effects |
| Q37096038 | IL4-10 Fusion Protein Is a Novel Drug to Treat Persistent Inflammatory Pain. |
| Q36866166 | Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy. |
| Q55141999 | Lifelong Impacts of Moderate Prenatal Alcohol Exposure on Neuroimmune Function. |
| Q49547270 | Mechanistic Differences in Neuropathic Pain Modalities Revealed by Correlating Behavior with Global Expression Profiling. |
| Q48536078 | Modulating inflammation in a cutaneous chronic wound model by IL-10 released from collagen-silica nanocomposites via gene delivery. |
| Q39306241 | Opioid Self-Administration is Attenuated by Early-Life Experience and Gene Therapy for Anti-Inflammatory IL-10 in the Nucleus Accumbens of Male Rats |
| Q47116857 | Prenatal alcohol exposure is a risk factor for adult neuropathic pain via aberrant neuroimmune function |
| Q39067961 | Prenatal alcohol exposure potentiates chronic neuropathic pain, spinal glial and immune cell activation and alters sciatic nerve and DRG cytokine levels. |
| Q99201607 | Pulsed Ultrasound Remedies Post-thoracotomy Hypersensitivity and Increases Spinal Anti-inflammatory Cytokine in Rats |
| Q92509428 | Rib soft fixation produces better analgesic effects and is associated with cytokine changes within the spinal cord in a rat rib fracture model |
| Q49923328 | Targeting cytokines for treatment of neuropathic pain. |
| Q64065590 | Targeting the β2-integrin LFA-1, reduces adverse neuroimmune actions in neuropathic susceptibility caused by prenatal alcohol exposure |
| Q37485007 | The therapeutic potential of interleukin-10 in neuroimmune diseases. |
Search more.